U.S. flag

An official website of the United States government

NM_000527.5(LDLR):c.1268T>C (p.Ile423Thr) AND Cardiovascular phenotype

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Mar 6, 2018
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002446477.2

Allele description [Variation Report for NM_000527.5(LDLR):c.1268T>C (p.Ile423Thr)]

NM_000527.5(LDLR):c.1268T>C (p.Ile423Thr)

Gene:
LDLR:low density lipoprotein receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.2
Genomic location:
Preferred name:
NM_000527.5(LDLR):c.1268T>C (p.Ile423Thr)
HGVS:
  • NC_000019.10:g.11113359T>C
  • NG_009060.1:g.28979T>C
  • NM_000527.5:c.1268T>CMANE SELECT
  • NM_001195798.2:c.1268T>C
  • NM_001195799.2:c.1145T>C
  • NM_001195800.2:c.764T>C
  • NM_001195803.2:c.887T>C
  • NP_000518.1:p.Ile423Thr
  • NP_000518.1:p.Ile423Thr
  • NP_001182727.1:p.Ile423Thr
  • NP_001182728.1:p.Ile382Thr
  • NP_001182729.1:p.Ile255Thr
  • NP_001182732.1:p.Ile296Thr
  • LRG_274t1:c.1268T>C
  • LRG_274:g.28979T>C
  • LRG_274p1:p.Ile423Thr
  • NC_000019.9:g.11224035T>C
  • NM_000527.4:c.1268T>C
  • P01130:p.Ile423Thr
  • c.1268T>C
Protein change:
I255T
Links:
LDLR-LOVD, British Heart Foundation: LDLR_001384; UniProtKB: P01130#VAR_005382; dbSNP: rs879254849
NCBI 1000 Genomes Browser:
rs879254849
Molecular consequence:
  • NM_000527.5:c.1268T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195798.2:c.1268T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195799.2:c.1145T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195800.2:c.764T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195803.2:c.887T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Cardiovascular phenotype
Identifiers:
MedGen: CN230736

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002682617Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Pathogenic
(Mar 6, 2018)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Expression of an LDL receptor allele with two different mutations (E256K and I402T).

Ekström U, Abrahamson M, Sveger T, Sun XM, Soutar AK, Nilsson-Ehle P.

Mol Pathol. 2000 Feb;53(1):31-6.

PubMed [citation]
PMID:
10884919
PMCID:
PMC1186899

Low-density lipoprotein receptor gene mutations in a Southeast Asian population with familial hypercholesterolemia.

Khoo KL, van Acker P, Defesche JC, Tan H, van de Kerkhof L, Heijnen-van Eijk SJ, Kastelein JJ, Deslypere JP.

Clin Genet. 2000 Aug;58(2):98-105.

PubMed [citation]
PMID:
11005141
See all PubMed Citations (4)

Details of each submission

From Ambry Genetics, SCV002682617.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

The p.I423T pathogenic mutation (also known as c.1268T>C), located in coding exon 9 of the LDLR gene, results from a T to C substitution at nucleotide position 1268. The isoleucine at codon 423 is replaced by threonine, an amino acid with similar properties. This alteration (historically described as p.I402T) has been reported in individuals with familial hypercholesterolemia and segregated with the disease in two apparently unrelated families (Ekström U et al. MP, Mol. Pathol., 2000 Feb;53:31-6; Khoo KL et al. Clin. Genet., 2000 Aug;58:98-105; Amsellem S et al. Hum. Genet., 2002 Dec;111:501-10; Wu WF et al. PLoS ONE, 2014 Apr;9:e94697). In addition, functional studies have suggested that this alteration would cause reduced protein activity in LDL binding and degradation (Ekström U et al. MP, Mol. Pathol., 2000 Feb;53:31-6). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024